astrazeneca-oxford-partnership
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
Combines Oxford University's world-class vaccinology expertise from the Jenner Institute and Oxford Vaccine Group with AstraZeneca's global development, manufacturing, and distribution capabilities to accelerate the availability of a COVID-19 vaccine.
Description Brand's website · 2026-10-04
A landmark agreement between AstraZeneca and the University of Oxford for the global development, manufacturing, and distribution of the ChAdOx1 nCoV-19 potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2.
Offerings
Core capabilities Brand's website · 2026-10-04
ChAdOx1 nCoV-19 (COVID-19 vaccine)
Pricing Brand's website · 2026-10-04
Not specified in the provided text.
Audience
Target industry Brand's website · 2026-10-04
Global population, particularly those in need of COVID-19 immunization, with a focus on low and middle-income countries.
Is this your business?
The information above is publicly sourced — assembled by Optimly from astrazeneca-oxford-partnership's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for astrazeneca-oxford-partnership across the index.
Claim astrazeneca-oxford-partnership — free →Page last updated 2026-10-17.